Zobrazeno 1 - 10
of 434
pro vyhledávání: '"Rudolf M Huber"'
Autor:
Kathrin Kahnert, Tanja Lucke, Rudolf M Huber, Jürgen Behr, Frank Biertz, Anja Vogt, Henrik Watz, Peter Alter, Sebastian Fähndrich, Robert Bals, Rolf Holle, Stefan Karrasch, Sandra Söhler, Margarethe Wacker, Joachim H Ficker, Klaus G Parhofer, Claus Vogelmeier, Rudolf A Jörres, COSYCONET consortium
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177501 (2017)
Although hyperlipidemia is common in COPD, its relationship to comorbidities, risk factors and lung function in COPD has not been studied in detail. Using the baseline data of the COSYCONET cohort we addressed this question. Data from 1746 COPD patie
Externí odkaz:
https://doaj.org/article/cb3189048cba4bd3bdb83bf08edaa52d
Autor:
Jeremias Götschke, Pontus Mertsch, Michael Bischof, Nikolaus Kneidinger, Sandhya Matthes, Ellen D Renner, Konrad Schultz, Claudia Traidl-Hoffmann, Hans-Werner Duchna, Jürgen Behr, Jürgen Schmude, Rudolf M Huber, Katrin Milger
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186632 (2017)
Climate change affects human health. The respective consequences are predicted to increase in the future. Patients with chronic lung disease are particularly vulnerable to the involved environmental alterations. However, their subjective perception a
Externí odkaz:
https://doaj.org/article/9bba3b682038491e9ddaffd5a451b2a3
Autor:
Tanja Lucke, Ronald Herrera, Margarethe Wacker, Rolf Holle, Frank Biertz, Dennis Nowak, Rudolf M Huber, Sandra Söhler, Claus Vogelmeier, Joachim H Ficker, Harald Mückter, Rudolf A Jörres, COSYCONET-Consortium
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0163408 (2016)
In large cohort studies comorbidities are usually self-reported by the patients. This way to collect health information only represents conditions known, memorized and openly reported by the patients. Several studies addressed the relationship betwee
Externí odkaz:
https://doaj.org/article/4b9eadf0c54a4950998601f61645d815
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0156268 (2016)
In vitro cell-based models of lung cancer are frequently employed to study invasion and the mechanisms behind metastasis. However, these models often study only one cell type with two-dimensional (2D) monolayer cell cultures, which do not accurately
Externí odkaz:
https://doaj.org/article/9006d3bf1cd045aebedaf3bf0313409e
Autor:
Holger Schulz, Claudia Flexeder, Jürgen Behr, Margit Heier, Rolf Holle, Rudolf M Huber, Rudolf A Jörres, Dennis Nowak, Annette Peters, H-Erich Wichmann, Joachim Heinrich, Stefan Karrasch, KORA Study Group
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63366 (2013)
BACKGROUND: Impulse oscillometry (IOS) is a non-demanding lung function test. Its diagnostic use may be particularly useful in patients of advanced age with physical or mental limitations unable to perform spirometry. Only few reference equations are
Externí odkaz:
https://doaj.org/article/974bb04dc0af4ef98edbe8cfbb209877
Autor:
Clemens Aigner, Hasan Batirel, Rudolf M. Huber, David R. Jones, Alan D.L. Sihoe, Tomaž Štupnik, Alessandro Brunelli
Publikováno v:
European Respiratory Review, Vol 33, Iss 171 (2024)
Surgery remains an essential element of the multimodality radical treatment of patients with early-stage nonsmall cell lung cancer. In addition, thoracic surgery is one of the key specialties involved in the lung cancer tumour board. The importance o
Externí odkaz:
https://doaj.org/article/2463c732387d4ae4aac9d310a2ae1853
Autor:
Scott N. Gettinger, MD, Rudolf M. Huber, MD, PhD, Dong-Wan Kim, MD, PhD, Lyudmila Bazhenova, MD, Karin Holmskov Hansen, MD, Marcello Tiseo, MD, Corey J. Langer, MD, FACP, Luis G. Paz-Ares Rodríguez, MD, PhD, Howard L. West, MD, Karen L. Reckamp, MD, MS, Glen J. Weiss, MD, Egbert F. Smit, MD, PhD, Maximilian J. Hochmair, MD, Sang-We Kim, MD, PhD, Myung-Ju Ahn, MD, PhD, Edward S. Kim, MD, FACP, Harry J.M. Groen, MD, PhD, Joanna Pye, MS, Yuyin Liu, PhD, Pingkuan Zhang, MD, Florin Vranceanu, MD, PhD, D. Ross Camidge, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 9, Pp 100385- (2022)
Introduction: We report brigatinib long-term efficacy and safety from phase 1/2 and phase 2 (ALTA) trials in ALK–rearrangement positive (ALK+) NSCLC. Methods: The phase 1/2 study evaluated brigatinib 30 to 300 mg/d in patients with advanced maligna
Externí odkaz:
https://doaj.org/article/78d40f5a880944a8b24323de142222e5
Autor:
Wouter H. van Geffen, Torsten G. Blum, Stefano Aliberti, Kevin G. Blyth, Clementine Bostantzoglou, Amy Farr, Bogdan Grigoriu, Georgia Hardavella, Rudolf M. Huber, Nick Maskell, Gilbert Massard, Najib M. Rahman, Daiana Stolz, Jan van Meerbeeck
Publikováno v:
Breathe, Vol 15, Iss 4, Pp 279-285 (2019)
Externí odkaz:
https://doaj.org/article/08e2f690cbac421f9473c6607c466124
Autor:
Kathrin Kahnert, Peter Alter, Tobias Welte, Rudolf M. Huber, Jürgen Behr, Frank Biertz, Henrik Watz, Robert Bals, Claus F. Vogelmeier, Rudolf A. Jörres
Publikováno v:
Respiratory Research, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background Recent investigations showed single associations between uric acid levels, functional parameters, exacerbations and mortality in COPD patients. The aim of this study was to describe the role of uric acid within the network of mult
Externí odkaz:
https://doaj.org/article/84439401edda4a97844a0a4c228a67a1
Autor:
Anna Kerpel-Fronius, Martin Tammemägi, Milena Cavic, Claudia Henschke, Long Jiang, Ella Kazerooni, Choon-Taek Lee, Luigi Ventura, Dawei Yang, Stephen Lam, Rudolf M. Huber, Javier Zulueta, Lucia Viola, Anant Mohan, Heidi Schmidt, Ricardo Sales dos Santos, Gabriella Sozzi, Rudolf Huber
Publikováno v:
Journal of Thoracic Oncology. 17:56-66
Screening with low-dose computed tomography of high-risk individuals with a smoking history reduces lung cancer mortality. Current screening guidelines and eligibility criteria can miss more than 50% of lung cancers, and in some geographic areas, suc